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Abstract
Eucalyptol is an essential oil that relaxes bronchial and vascular
smooth muscle although its direct actions on isolated myocardium
have not been reported. We investigated a putative negative inotropic
effect of the oil on left ventricular papillary muscles from male Wistar
rats weighing 250 to 300 g, as well as its effects on isometric force, rate
of force development, time parameters, post-rest potentiation, posi-
tive inotropic interventions produced by Ca2+ and isoproterenol, and
on tetanic tension. The effects of 0.3 mM eucalyptol on myosin
ATPase activity were also investigated. Eucalyptol (0.003 to 0.3 mM)
reduced isometric tension, the rate of force development and time
parameters. The oil reduced the force developed by steady-state
contractions (50% at 0.3 mM) but did not alter sarcoplasmic reticulum
function or post-rest contractions and produced a progressive increase
in relative potentiation. Increased extracellular Ca2+ concentration
(0.62 to 5 mM) and isoproterenol (20 nM) administration counteracted
the negative inotropic effects of the oil. The activity of the contractile
machinery evaluated by tetanic force development was reduced by 30
to 50% but myosin ATPase activity was not affected by eucalyptol (0.3
mM), supporting the idea of a reduction of sarcolemmal Ca2+ influx.
The present results suggest that eucalyptol depresses force develop-
ment, probably acting as a calcium channel blocker.
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Introduction
Eucalyptol, 1,8 cineole, is an essential oil
present in large amounts in a variety of plants
which is frequently used in the manufacture
of cosmetics, to increase percutaneous pen-
etration of drugs, as a nasal decongestant and
anticough agent, in aromatherapy, and in
dentistry (1-4). Eucalyptol has been used to
treat bronchitis, sinusitis and chronic rhinitis
and also for the treatment of asthma (5).
These actions seem to be related to an anti-
inflammatory action (6) inhibiting the pro-
duction of tumor necrosis factor alpha (7).
The oil also inhibits the production of cyto-
kines and prostaglandins by stimulated mono-
cytes in vitro, explaining its bronchodilator
effect (7). Gastric protection preventing etha-
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nol-induced injury was also reported in rats
(8). This compound also enhances blood
circulation, leading to skin hyperemia after
local application (9). Other reports have
shown that prolonged exposure to eucalyp-
tol (inhalation) increases cerebral blood flow
correlated with eucalyptol concentration in
blood (10), suggesting a vasodilator action.
Cardiovascular effects were also recently
reported. Lahlou et al. (11) showed that eu-
calyptol reduced heart rate by a parasympa-
thetic-dependent action and induced hypo-
tension by a direct vasorelaxation.
Eucalyptol is metabolized to 2-exo-hy-
droxy-1,8 cineole by microsomes from hu-
man and rat liver, but it is not clear whether
this substance can be metabolized by hu-
mans in vivo (12). Eucalyptol diffuses faster
by inhalation than by oral administration or
through the skin (9,13). Its presence can be
detected in blood 5 min after inhalation, with
maximal concentration being reached within
18 min (14).
Non-fatal symptoms were observed in
children following nasal administration of
eucalyptol. Effects included mucous mem-
brane irritation, tachycardia, dyspnea, nau-
sea, vomiting, muscle weakness, somnolence,
and coma (15). Accidental ingestion by a 3-
year-old boy was reported, causing depres-
sion of the central nervous system (16). Fatal
episodes have also been reported in humans
(17) resulting from accidental exposure and
also from large-volume mouthwash inges-
tion that contributed to severe anion-gap
metabolic acidosis and osmolar gap, result-
ing in multiple organ system failure and
death (18).
Since eucalyptol relaxes bronchial and
vascular smooth muscle, it may have a puta-
tive direct action on the heart muscle. How-
ever, the actions of eucalyptol on cardiac
contraction and contractile proteins have not
been described. Hence, the present study
was designed to investigate the actions of the
oil on the contractile activity of cardiac
muscle.
Material and Methods
Male Wistar rats weighing 250 to 300 g
were used. Care and use of laboratory ani-
mals were in accordance with NIH guide-
lines. The rats received 500 units heparin ip
and after 10 min they were anesthetized with
45 mg/kg sodium pentobarbital, ip. After
thoracotomy, the hearts were rapidly removed
and perfused through the aortic stump to
permit proper selection and dissection of left
ventricle papillary muscles. The preparations
were mounted in a plexiglas chamber con-
tinuously superfused with gassed (95% O2
and 5% CO2) Krebs bicarbonate buffer solu-
tion of the following composition: 120 mM
NaCl, 5.4 mM KCl, 1.2 mM MgCl26H2O,
1.25 mM CaCl22H2O, 2.0 mM NaH2PO4H2O,
1.2 mM Na2SO4, 27 mM NaHCO3, and 11
mM glucose, at 29 ± 1ºC. Muscles stretched
to LMAX (muscle length at which active ten-
sion is maximal) were stimulated with iso-
lated rectangular pulses (10 to 15 V, 12-ms
duration) through a pair of platinum elec-
trodes placed along the entire extension of
the muscle. The standard stimulation rate
was 0.5 Hz (steady state). Recording was
started after 60 min to permit the beating
preparation to adapt to the new environmen-
tal conditions.
The following parameters were analyzed:
peak isometric force and its first time deriva-
tive, time to peak tension, relaxation time,
taken as the time measured from the begin-
ning to the peak force and from the peak
force to the end of the contraction, respec-
tively, relative potentiation obtained after a
pause of 15 s, before and after eucalyptol
treatment under steady-state stimulation.
Protocols
Muscles were stretched to LMAX and kept
under steady-state conditions. Developed
force was measured with an isometric force
transducer (Nihon-Kohden, TB 612T, To-
kyo, Japan), recorded on a chart recorder
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(Nihon-Kohden, RM-6200), and normalized
to the muscle cross-sectional area (g/mm2).
Considering the papillary muscle as a cylin-
der and tissue density as 1, the cross-sec-
tional area was calculated by dividing the
muscle length at LMAX by its weight. The first
time derivative was obtained with a differen-
tiator amplifier (Nihon-Kohden ED 601-G).
Calibration was obtained by recording con-
traction at high velocity and drawing a straight
line at the highest slope of the ascending
portion of the contraction curve. This slope
corresponds to the ratio between force (in g/
mm2) and time (in s), which is the peak or
maximum first time derivative.
To avoid the possibility of a hypoxic core
we performed experiments at low tempera-
ture (29 ± 1ºC), as previously described (19).
To investigate the actions of increasing eu-
calyptol concentrations on sarcoplasmic
reticulum activity, a 15-s pause interval was
used as previously described (20), and the
results are presented as relative potentiation
(the amplitude of post-rest contractions di-
vided by steady-state contractions).
The following protocols were used:
1) The effects of eucalyptol (0.003, 0.007,
0.01, 0.03, 0.07, 0.1, and 0.3 mM) on cardiac
contractions were tested in 8 preparations
(cross-sectional area = 0.9 ± 0.06 mm2).
2) Under steady-state conditions, force
was measured at increasing Ca2+ concentra-
tions (0.62, 1.25, 2.5, 3.75, and 5 mM) in the
absence (cross-sectional area = 1.10 ± 0.11
mm2, N = 12) and in the presence of 0.3 mM
eucalyptol. In another group of papillary
muscles (cross-sectional area = 0.96 ± 0.05
mm2, N = 12), under steady-state conditions,
the positive inotropic effect produced by
(-)isoproterenol (20 nM) was investigated
with or without 0.3 mM eucalyptol.
3) The influence of eucalyptol (0.01, 0.05,
0.1, and 0.5 mM) on the contractile proteins
was studied in another group of papillary
muscles (cross-sectional area = 0.98 ± 0.06
mm2, N = 10) during tetanic stimulations.
Tetanic tension was obtained after treatment
with 5 mM caffeine for 20 min at a rate of 10
Hz for 15 s, as previously described (21).
Tetanic contractions developed a fast
upstroke, with the peak being measured as
tetanic peak force, followed by a slow decay
and a plateau, tetanic plateau force, meas-
ured at the middle of the plateau. Between
tetanic stimuli the muscles remained under
steady-state stimulation for at least 10 min.
To insure that the effects of eucalyptol were
not dependent on time, a time control was
performed in another group of papillary
muscles (cross-sectional area = 1.04 ± 0.03
mm2, N = 18) under the same conditions.
Finally, to observe the recovery of muscle
contraction, at the end of these experiments
the preparations were washed twice with
Krebs solution and kept under steady-state
conditions, and tension was measured after
60 min.
4) The action of 0.3 mM eucalyptol on
myosin ATPase activity was also studied.
Tissue preparation
Tissue samples (left ventricles) were
quickly harvested, rinsed, blotted, and ho-
mogenized. Myosin was prepared from
minced and homogenized left ventricles (N
= 5), and extracted briefly with KCl-phos-
phate buffer (0.3 M KCl, 0.2 M phosphate
buffer, pH 6.5) (22). After myosin precipita-
tion by 15-fold dilution with water, the muscle
residue was separated by filtration through a
cheesecloth. This procedure precipitates frag-
ments of cells including membranes. The
filtrate containing myosin was centrifuged at
33,000 g for 30 min. After decanting the
supernatant the precipitate was redissolved
in 0.6 M KCl for elution of myosin under
high ionic strength and 1 ml water was added
to each g of tissue to produce a new precipi-
tate. The material was again centrifuged at
33,000 g for 30 min and the muscle residue
separated by filtration. The material was re-
dissolved again in 14 ml of water per g of
tissue, centrifuged and filtered as before.
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The precipitate was dissolved in 50 mM
HEPES, pH 7.0, and 0.6 M KCl plus 50
glycerol (v/v) and stored at -20ºC. Before
use, the stocked myosin was diluted in water
(1:12) and centrifuged at 600 g for 15 min.
The precipitate was resuspended in 50 mM
HEPES, pH 7, and 0.6 M KCl, and centri-
fuged at 600 g again. The supernatant was
used for enzyme assays.
Assay of myosin ATPase activity
Myosin ATPase activity was assayed
(23,24) by measuring Pi liberation from 1
mM ATP in the presence of 50 mM HEPES,
pH 7, 0.6 M KCl, 5 mM CaCl2 or 10 mM
EGTA in a final volume of 200 µl. In the
presence of this high ionic strength with no
addition of Mg2+ to the incubation medium,
only myosin activity is measured and there is
no significant activity of Mg2+-ATPase,
which is an actin-contaminated myosin.
These assay conditions also excluded the
activity of Ca2+-ATPase from the sarcoplas-
mic reticulum membranes that require high
Mg2+ and low Ca2+ concentrations. ATP was
added to the reaction mixture and pre-incu-
bated for 5 min at 30ºC. The reaction was
initiated by adding the enzyme fraction (3-5
µg protein) to the reaction mixture. Incuba-
tion times and protein concentration were
chosen in order to ensure linearity of the
reaction. Samples were assayed in duplicate
or triplicate and corrected for non-enzymatic
hydrolysis by using controls assayed under
the same conditions, except that the protein
sample was added after the reaction was
stopped with 200 µl of 10% trichloroacetic
acid. The reaction was initiated by adding
the protein sample to avoid the inactivation
at 30ºC caused by the lack of substrate. The
enzyme activity was calculated as the differ-
ence between the activity observed in the
presence of Ca2+ and the activity observed in
the presence of 10 mM EGTA. Inorganic
phosphate was determined by the method of
Chan et al. (25). The specific activity was
reported as nmol Pi released per min per mg
protein. To determine whether eucalyptol
affected myosin ATPase activity, protein
samples were incubated with a 0.3 mM con-
centration of the oil.
Protein determination
Protein was measured by the Coomassie
blue method according to Bradford (26) us-
ing bovine serum albumin as standard.
Drugs and reagents used
ATP, dithiothreitol, reduced glutathione,
HgCl2 (mercuric chloride), EGTA (ethylene
glycol-bis (ß-amino ethyl ether)-N,N,N’,N’-
tetra acetic acid), HEPES (N-[2-hydroxy-
ethyl]piperazine-N’-[2-ethanesulfonic acid]),
sodium salt, (-)isoproterenol hydrochloride,
and anhydrous caffeine were purchased from
Sigma (St. Louis, MO, USA), KCl, CaCl2,
and KH2PO4 were purchased from Merck
(Darmstadt, Germany); pentobarbital so-
dium, 30 mg, was from Cristalia, Produtos
Químicos Farmacêuticos Ltda. (São Paulo,
SP, Brazil); heparin, 5000 IU was from
Roche Q.F.S.A. (Rio de Janeiro, RJ, Brazil);
eucalyptol was purchased from S.S. White
(Rio de Janeiro, RJ, Brazil). All other re-
agents were of analytical grade from Sigma,
Merck or Reagen (Rio de Janeiro, RJ, Bra-
zil).
Stock solutions were prepared with euca-
lyptol solubilized in a mixture of 5% Tween
80 (100 or 1 mM) plus distilled fresh water
and, after vigorous shaking, were added to
the bath solution in an appropriate volume,
never greater than 1% Krebs solution, to
obtain the desired concentration.
Statistical analysis
Data are reported as means ± SEM with
N for number of observations. Comparisons
were made by the Student t-test or one- or
two-way ANOVA. When a significant
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ANOVA was obtained, the Tukey test was
applied. The level of significance was set at
P < 0.05. All analyses and data plots were
performed using the GraphPad Prism™ (ver-
sion 2.0, GraphPad Software, San Diego,
CA, USA) and GB-STAT (version 4.0, Dy-
namic Microsystem Inc., Silver Spring, MD,
USA) software.
Results
Figure 1 shows the effects of eucalyptol
concentrations on the isometric force devel-
oped by papillary muscles. Eucalyptol re-
duced the force in a concentration-depend-
ent manner (Figure 1), and 50% force reduc-
tion compared to control, that was taken as
100%, was attained at 0.3 mM. The first time
derivative was also reduced, reproducing the
same behavior as observed for force (results
not shown). Eucalyptol also reduced time
parameters, time to peak tension and relax-
ation time of the isometric contractions (Fig-
ure 2) in a concentration-dependent manner.
Post-rest potentiation was used to deter-
mine whether eucalyptol affects the function
of the sarcoplasmic reticulum. Post-rest con-
tractions (PRCs) obtained after 15-s pauses
at different eucalyptol concentrations were
recorded and analyzed as relative potentia-
tion. Increasing eucalyptol concentrations
produced a progressive increase in relative
potentiation (Figure 3).
The physiological and pharmacological
control of heart contractility can be exerted
through changes in extracellular Ca2+ con-
centration. The dependence of force devel-
opment upon changes in external Ca2+ con-
centrations (0.62, 1.25, 2.5, 3.75, and 5 mM)
in the absence and presence of eucalyptol
(0.3 mM) is shown in Figure 4, upper panel.
Although it reduced force, eucalyptol did
not block the increase in force in response to
increasing Ca2+ concentrations.
The influence of eucalyptol on the posi-
tive inotropic effect produced by isoprote-
renol was investigated. Figure 4, lower panel,
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Figure 1. Effect of increasing
concentrations of eucalyptol on
the isometric force developed
by rat papillary muscles. Data
are reported as means ± SEM
for N = 8. *P < 0.05 for eucalyp-
tol vs control (C, one-way
ANOVA).
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Figure 2. Effect of increasing
concentrations of eucalyptol on
the parameters time to peak
tension (TPT, upper panel) and
relaxation time (lower panel) of
the isometric force developed
by rat papillary muscles. Data
are reported as means ± SEM
for N = 8. *P < 0.05 for eucalyp-
tol vs control (C, one-way
ANOVA).
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Figure 3. Effect of increasing
concentrations of eucalyptol on
the relative potentiation ob-
tained after pauses of 15 s dura-
tion. Results are reported as
means ± SEM for N = 8. *P <
0.05 for eucalyptol vs control (C,
one-way ANOVA).
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shows that at low Ca2+ concentration, the
negative inotropic effect elicited by eucalyp-
tol was reversed by isoproterenol (20 nM).
We also investigated whether the depres-
sant action of eucalyptol only occurred via
Ca2+ influx or might affect contractile pro-
teins. For this purpose, tetanic contractions
were induced after treatment with 5 mM
caffeine. As expected, isometric force re-
duction was observed after 20 min. Tetanic
contractions developed a fast upstroke (te-
tanic peak force) followed by a slow and
progressive decay. Figure 5 shows that euca-
lyptol depressed the tetanic contractions de-
veloped by papillary muscles in a concentra-
tion-dependent manner. This action was ob-
served both at tetanic peak force and at the
middle of the force decay (plateau force).
However, tetanic contractions might change
as a function of time under control condi-
tions. When we investigated time-dependent
effects (time controls) on tetanic contrac-
tions, we found no differences in the tetanic
peak force or at the middle of force decay
(results not shown).
To investigate whether tetanic tension
reduction depends on eucalyptol actions, the
contractile protein activity of the myosin
ATPase (24) was measured. Eucalyptol (0.3
mM) did not affect the myosin Ca2+-ATPase
activity (control: 487 ± 32.7 vs eucalyptol:
491 ± 33.1 nmol Pi min-1 mg-1 protein, P >
0.05).
At the end of experiments with tetanic
contractions the reversibility of eucalyptol
effects was determined. Papillary muscles
were washed twice and force measured again
after 60 min (control tetanic tension before
eucalyptol treatment: 1.67 ± 0.15, tetanic
tension in the presence of eucalyptol: 0.56 ±
0.08, and tension after washing and no euca-
lyptol: 1.26 ± 0.16 g/mm2, N = 10; P < 0.05
for comparison among tetanic tension and
control or tension after washing, one-way
ANOVA). With the concentrations of euca-
lyptol used, force reversibility was close to
70% of the control.
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Figure 4. Effect of 0.1 mM euca-
lyptol on the isometric force de-
veloped by rat papillary muscles
under increasing Ca2+ concen-
trations (upper panel). Data are
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trol (0.62 mM Ca2+; one-way
ANOVA).
Te
ta
ni
c 
fo
rc
e-
pl
at
ea
u 
(g
/m
m
2 )
1.00
0.75
0.50
0.25
0.00
Te
ta
ni
c 
fo
rc
e-
pe
ak
 (
g/
m
m
2 )
2.0
1.5
1.0
0.5
0.0
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
..............................................................................................................................................................................
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
1234
C 10 30 300 700
Eucalyptol concentration (µM)
C 10 30 300 700
Eucalyptol concentration (µM)
*
*
*
*
Figure 5. Effect of increasing
concentrations of eucalyptol on
the tetanic force development
measured at peak (upper panel)
and half decay time (lower
panel). Data are reported as
means ± SEM for N = 10. *P <
0.01 for eucalyptol vs control (C,
one-way ANOVA).
....................................................................................................................................
C
459
Braz J Med Biol Res 38(3) 2005
Myocardial effect of eucalyptol
Discussion
The present results show that eucalyptol
depresses the isometric contraction devel-
oped by rat papillary muscles in a dose-
dependent manner without affecting the func-
tion of the sarcoplasmic reticulum. This ef-
fect seems to be the result, in part, of calcium
channel blockade because eucalyptol reduced
the development of tetanic tension.
Eucalyptol is a monoterpene, one of the
main components of essential oils used as
aromatic compounds. In dentistry it is used
as a temporary dressing and as a lubricant for
root canal filling material or as a gutta-percha
solvent (3,4). Used as a drug, this compound
has several actions including bronchodilata-
tion (5,7) and vasodilatation of cerebral ar-
teries (10). According to Juergens et al. (7),
these actions may be related to inhibitory
effects on the synthesis of cytokines and
prostaglandins. Recently, cardiovascular ac-
tions were reported (11) examining whether
the autonomic nervous system is involved,
showing that eucalyptol induced hypoten-
sion and bradycardia in either conscious or
anesthetized rats and dose-dependently re-
duced potassium-induced contractions in
aortic rings. However, direct actions of eu-
calyptol on the cardiac muscle or contractile
proteins were not described yet. Moreover,
other compounds of essential oils, such as
eugenol and isoeugenol, produce vasodilata-
tion (27,28) and depress cardiac contrac-
tions acting via calcium channels (29). Our
results show that eucalyptol reduced the iso-
metric force developed by papillary muscles
in a dose-dependent manner. The compound
also affected the temporal parameters, with
both time to peak tension and relaxation time
being slightly reduced, in agreement with a
calcium channel blocker action of the com-
pound (30).
The force developed during cardiac
muscle contraction is altered in response to
changes in rate and rhythm (31). In cardiac
muscle, the contractions occurring after short
pauses are potentiated (20). In several spe-
cies these PRCs usually become reduced in
force as the rest periods increase (32). The
rat cardiac muscle, different from other mam-
malian species, increases its force as the rest
period increases (33). Mill et al. (20) re-
ported that, despite these interspecies differ-
ences, PRCs depend on pause duration and
on the amount of calcium stored at intracel-
lular sites. This suggests that there is a sig-
nificant difference between the activation
processes of steady-state contraction (SSC)
and PRC. The relative participation of the
sarcoplasmic reticulum is more important
for PRCs than for SSCs. Hence, if PRCs
were more dependent on stored intracellular
Ca2+ than SSCs, maneuvers which modify
the transmembrane Ca2+ influx should affect
SSCs more than PRCs. Regarding the ac-
tions of eucalyptol, although SSCs were pro-
gressively depressed, the PRCs were dose-
dependently potentiated. This finding sug-
gests that eucalyptol did not interfere with
sarcoplasmic reticulum function and its ef-
fects were much more dependent on mem-
brane Ca2+ influx through voltage-sensitive
channels than on Ca2+ release from sarco-
plasmic reticulum. Similar results were ob-
tained in investigations of the effects of two
Ca2+ channel blockers, verapamil and man-
ganese (20). Therefore, if Ca2+ entry is par-
tially blocked, the relative participation of
the sarcoplasmic reticulum in tension devel-
opment increases and the first contraction
after a pause is potentiated.
ß-Adrenoceptor stimulation with isopro-
terenol increases the transmembrane Ca2+
influx and produces a faster Ca2+ uptake by
the sarcoplasmic reticulum (34), which re-
sults in forceful and faster myocardial con-
traction. This positive inotropic effect of
isoproterenol is small in isolated rat heart
preparations at 1.25 and 2.5 mM Ca2+ con-
centrations (19). Since the rat myocardium
saturates its positive inotropic response at
extracellular Ca2+ concentrations lower than
those for other species (19), protocols were
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performed at low extracellular Ca2+ (0.62
mM CaCl2) concentrations. We, therefore,
investigated if increasing Ca2+ concentration
(0.62 to 5 mM CaCl2) or isoproterenol ad-
ministration reversed the negative inotropic
response induced by eucalyptol. When
muscles were treated with eucalyptol, force
was reduced but the positive inotropic ef-
fects produced by increasing Ca2+ concen-
tration or isoproterenol administration were
not reversed.
In cardiac preparations, tetanic contrac-
tions are obtained after inhibition of sarco-
plasmic reticulum activity with caffeine or
ryanodine and this maneuver has been used
to produce maximal activation of the con-
tractile machinery in the intact myocardium
(21,35-37). Caffeine acts by depleting the
sarcoplasmic reticulum of its calcium con-
tent and also by inhibiting Ca2+ reuptake.
The molecular site of action of caffeine also
seems to be the ryanodine receptor (38).
Eucalyptol clearly affected contractile
proteins, reducing tetanic tension. To be sure
that the elicited tension decay was not a
time-dependent cellular fatigue, time con-
trol experiments were performed. The re-
sults showed no difference in tension decay
along the time course of the experiments.
Thus, the effect of eucalyptol, rather than
time, reduced the tension developed by pap-
illary muscles during tetanic stimulation.
Since sarcoplasmic reticulum activity is
abolished, this force reduction could be due
to two mechanisms, i.e., reduction of the
activity of the contractile machinery by eu-
calyptol by affecting myosin ATPase, or by
reducing Ca2+ influx. To investigate if te-
tanic tension reduction was dependent on
the actions of contractile proteins, we inves-
tigated the effect of eucalyptol on myosin
ATPase activity. Eucalyptol (0.3 mM) was
found to be unable to affect myosin Ca2+-
ATPase activity, a fact supporting the sug-
gestion of its Ca2+ channel blocker action.
To exclude possible irreversible toxic
actions of eucalyptol produced by the con-
centrations used, normal Krebs solution with-
out the oil was used at the end of the experi-
ments with tetanic stimulation. Sixty min-
utes later it was possible to observe that
muscle contractions recovered 70% of con-
trol force, suggesting that the concentrations
used did not produce permanent myocyte
damage.
This is the first report showing a new
action of this monoterpene suggesting that:
1) eucalyptol depresses myocardial contrac-
tility in a concentration-dependent way and
2) increases the relative potentiation sug-
gesting no interference with the function of
the sarcoplasmic reticulum; 3) the negative
inotropic effect of eucalyptol was reversed
by Ca2+ and isoproterenol; 4) the depressant
effect of eucalyptol on tetanic contractions
without reduction of the activity of myosin
ATPase also suggests a reduction of Ca2+
influx.
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